All | Completers | |||
---|---|---|---|---|
Placebo (N=25) | Fish oil (N=25) | Placebo (N=14) | Fish oil (N=18) | |
Demographics | ||||
Sex, female | 22 (88 %) | 20 (80 %) | 11 (79 %) | 14 (78 %) |
Age, years | 36.1 [28.6–41.0]a | 46.1 [34.7–49.3]a | 35.6 [26.3–42.7]a | 46.2 [36.8–49.1]a |
Ethnicity | ||||
Hispanic/Latino | 11 (44 %) | 11 (44 %) | 7 (50 %) | 8 (44 %) |
Black/African American | 13 (52 %) | 14 (56 %) | 6 (43 %) | 10 (56 %) |
White | 1 (4 %) | 0 (0 %) | 1 (7 %) | 0 (0 %) |
BMI | 25.0 [23.4–32.6]a | 31.4 [27.5–40.2]a | 26.0 [23.7–33.0]a | 35.4 [29.0–42.0]a |
Rate Your Plate | 55 [50–60] | 57 [52–63] | 56 [50–61] | 58 [53–64] |
Comorbidities | ||||
HTN | 13 (52 %)a | 20 (8O%)a | 6 (43 %)a | 15 (83 %)a |
DM2 | 1 (4 %) | 6 (24 %) | 1 (7 %) | 4 (22 %) |
Tobacco Use | 5 (20 %) | 7 (28 %) | 5 (36 %) | 6 (33)% |
Disease Characteristics | ||||
SELENA-SLEDAI | 8 [2–10] | 6 [3–10.5] | 4 [0–3.5] | 7 [3.5–11.25] |
Disease duration, years | 6 [2–10] | 6 [3–11] | 5.5 [l.8–9.3] | 6 [2.8–10.5] |
ACR Criteria, total number | 6 [5–7] | 5 [5–7] | 5 [4–7] | 5.5 [5–7] |
Lupus Nephritis | 18 (72 %) | 17 (68 %) | 10 (71 %) | 14 (78 %) |
Medication | ||||
Prednisone | ||||
0 mg/day | 7 (28 %) | 11 (44 %) | 5 (36 %) | 7 (39 %) |
≤7.5 mg/day | 8 (32 %) | 4 (16 %) | 5 (36 %) | 2 (11 %) |
>7.5 mg/day | 10 (40 %) | 10 (40 %) | 4 (29 %) | 9 (50 %) |
Hydroxychloroquine | 22 (88 %) | 22 (88 %) | 12 (86 %) | 16 (89 %) |
Other Immunosuppressants | ||||
Cyclophosphamide | 0 (0 %) | 2 (8 %) | 0 (0 %) | 1 (6 %) |
Mycophenolate | 11 (44 %) | 11 (44 %) | 8 (57 %) | 7 (39 %) |
Azathioprine | 4 (16 %) | 1 (4 %) | 2 (14 %) | 0 (0 %) |
Misc. Medications | ||||
Statin | 5 (20 %) | 8 (32 %) | 2 (14 %) | 7 (39 %) |
ACEI/ARB | 16 (64 %) | 15 (60 %) | 9 (64 %) | 12 (67 %) |